DualityBio-B (09606) has announced that, under its pre-IPO equity incentive plan adopted on February 28, 2021 and amended on June 25, 2023, 18,100 ordinary shares were issued upon the exercise of granted share options.
Additionally, under the same pre-IPO equity incentive plan adopted on February 28, 2021 and amended on June 25, 2023, 60,000 ordinary shares were issued upon the exercise of granted share options.
In total, the company issued 7.81 million shares pursuant to the exercise of share options.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments